MRK241206C102000
- 1.05
- +0.51+94.44%
Merck & Co Newsroom
Nasdaq, S&P Ebb Near Record Highs, Dow Slips as JOLTS Report Kicks off Run of Jobs Data
Express News | Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Merck & Co., Inc.'s (NYSE:MRK) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Merck Say Lung Cancer Treatment Receives FDA Breakthrough Therapy Designation
Express News | FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (Sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With Egfr Mutations
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Merck & Co Unusual Options Activity For December 02
Bernstein Maintains Merck & Co(MRK.US) With Hold Rating, Cuts Target Price to $110
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December Starts With a Mixed Market | Live Stock
Bernstein Trims Price Target on Merck to $110 From $115
Merck (MRK.US) antibiotic combination has been approved for sale in China.
Merck (MRK.US) antibiotic combination has been approved for sale in China.
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study